Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (1) Daniel, Peter Prof. Dr. (1) Kammertöns, Thomas Dr. (5) Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (7) (-) Blankenstein, Thomas Prof. Dr. (22) (-) Bunse, Mario Dr. (1) (-) Kopp, Joachim Dr. (1) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Experimentelle Ultrahochfeld-MR (1) Genetik metabolischer und reproduktiver Störungen (2) Magnetic Resonance (1) (-) Molekulare Immunologie und Gentherapie (22) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) (-) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (1) (-) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) (-) 2013 (11) 2014 (3) 2015 (4) 2016 (5) 2017 (6) 2018 (6) 2019 (7) 2020 (2) 2021 (4) 2022 (12) 2023 (10) 2024 (3) 22 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Bunse, Mario Dr.Kopp, Joachim Dr.Molekulare Immunologie und Gentherapie 2002200620072013 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 03. Juni 2002 / J Exp Med Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction Z. Qin H.J. Kim J. Hemme T. Blankenstein 15. Mai 2002 / Canc Res Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors Z. Qin C. Harders X. Cao C. Huber T. Blankenstein B. Seliger 01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel 01. August 2002 / J Mol Med Naive CD8+ but not CD4+ T cells induce maturation of dendritic cells T. Schueler T. Blankenstein 01. April 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Januar 2007 / J Immunother T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging R. Agger M.S. Petersen C.C. Petersen S.B. Hansen H. Stodkilde-Jorgensen U. Skands T. Blankenstein T.E. Andersen E.F. Hulgaard J.T. Jorgensen J. Marqversen H.J. Gundersen M.E. Hokland 01. August 2007 / Semin Cancer Biol Do autochthonous tumors interfere with effector T cell responses? T. Blankenstein 01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein 15. Oktober 2007 / J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
03. Juni 2002 / J Exp Med Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction Z. Qin H.J. Kim J. Hemme T. Blankenstein
15. Mai 2002 / Canc Res Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors Z. Qin C. Harders X. Cao C. Huber T. Blankenstein B. Seliger
01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
01. August 2002 / J Mol Med Naive CD8+ but not CD4+ T cells induce maturation of dendritic cells T. Schueler T. Blankenstein
01. April 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Januar 2007 / J Immunother T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging R. Agger M.S. Petersen C.C. Petersen S.B. Hansen H. Stodkilde-Jorgensen U. Skands T. Blankenstein T.E. Andersen E.F. Hulgaard J.T. Jorgensen J. Marqversen H.J. Gundersen M.E. Hokland
01. August 2007 / Semin Cancer Biol Do autochthonous tumors interfere with effector T cell responses? T. Blankenstein
01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
15. Oktober 2007 / J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein